Recherche
-
Antiviral efficacy of favipiravir against Zika and SARS-CoV-2 viruses in non-human primates
(Nature Communications. vol. 13, n° 1, 2022-08-30)Article de revueLibre accès -
Social cognition in neuropsychology: A nationwide survey revealing current representations and practices
(Applied Neuropsychology: Adult, 2022)Article de revueLibre accès -
Les leucémies et lymphomes induits par le virus HTLV-1 en Guyane : données de vie réelle de 2009 à 2019
(2022-05-18)Thèse d'exerciceAccès réservé -
Ribavarin for treating Lassa fever: A systematic review of pre-clinical studies and implications for human dosing
(PLoS Neglected Tropical Diseases. vol. 16, n° 3, 2022-03)Article de revueLibre accès -
Bronchial epithelia from adults and children: SARS-CoV-2 spread via syncytia formation and type III interferon infectivity restriction
(Proceedings of the National Academy of Sciences of the United States of America. vol. 119, n° 28, 2022-07-12)Article de revueLibre accès -
The number of cases, mortality and treatments of viral hemorrhagic fevers: A systematic review
(PLoS Neglected Tropical Diseases. vol. 16, n° 10, pp. e0010889, 2022-10-31)Article de revueLibre accès -
Development of the PREDS score to predict in-hospital mortality of patients with Ebola virus disease under advanced supportive care: Results from the EVISTA cohort in the Democratic Republic of the Congo
(EClinicalMedicine. vol. 54, 2022-12)Article de revueLibre accès -
A standardised Phase III clinical trial framework to assess therapeutic interventions for Lassa fever
(PLoS Neglected Tropical Diseases. vol. 16, n° 1, 2022-01-06)Article de revueLibre accès -
Post-vaccination SARS-cov-2 infection in nursing home residents, Bordeaux, France
(Journal of Clinical Virology. vol. 149, 2022-03-15)Article de revueLibre accès -
High doses of favipiravir in two men survivors of Ebola virus disease carrying Ebola virus in semen in Guinea
(IDCases. vol. 27, 2022-02)Article de revueLibre accès